40425_2018_403_MOESM2_ESM.docx (19.07 kB)
Additional file 2: of Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8+ T cells in the tumor microenvironment
journal contribution
posted on 2018-10-11, 05:00 authored by Yasuko Tada, Yosuke Togashi, Daisuke Kotani, Takeshi Kuwata, Eichi Sato, Akihito Kawazoe, Toshihiko Doi, Hisashi Wada, Hiroyoshi Nishikawa, Kohei ShitaraTable S2. Patient characteristics. (DOCX 19 kb)